Yunji Inc. (YJ)
NASDAQ: YJ · Real-Time Price · USD
1.880
+0.080 (4.44%)
May 8, 2026, 4:00 PM EDT - Market closed

Yunji Earnings Call Transcripts

Fiscal Year 2025

  • Revenue reached CNY 158.7 million in H2 2025, with merchandise sales up 0.16% year-over-year and net loss narrowing by 70% to CNY 32.6 million. Strong growth in organic health products and user engagement drove improved margins and operational efficiency.

  • Revenue declined year-over-year due to market headwinds, but gross margin remained strong at 47.3%. Key product launches in health and beauty segments drove brand growth, while operating losses widened. Focus remains on cost optimization, margin improvement, and sustainable expansion.

Fiscal Year 2024

  • Revenue grew 32% year-over-year in Q4 2024, with gross margin at 48.3% and a high user repurchase rate of 71.9%. Strategic business consolidation, new wellness initiatives, and private label expansion aim to drive future growth despite a wider net loss.

  • Revenue declined year-over-year due to softer consumer confidence, but gross margin remained strong at 54.1%. Operating and net losses narrowed, and liquidity remains robust with no long-term debt. Offline wellness expansion and digital innovation support future growth.

  • Revenue declined year-over-year due to softer consumer confidence and product adjustments, but gross margin remained strong at 46.6%. Net loss narrowed significantly, and the company launched its first offline wellness store while maintaining a solid cash position.

  • Q1 2024 saw revenues decline year-over-year, but gross margin remained strong at 49.4% and net income turned positive. Strategic focus included expanding health and wellness initiatives, leveraging short video and live streaming, and maintaining robust cash reserves.

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021

Powered by